Kamada Opens New Plasma Center in Houston
Company Announcements

Kamada Opens New Plasma Center in Houston

Kamada (KMDA) has released an update.

Kamada Ltd. has expanded its plasma collection operations with a new center in Houston, Texas, expected to annually collect around 50,000 liters of plasma and contribute $8 to $10 million in revenue at full capacity. This center will focus on both normal source plasma and specialized types like Anti-Rabies and Anti-D, aiming to be one of the largest specialty plasma collection sites in the U.S. Additionally, the company is constructing a third center in San Antonio, slated to open in the first half of 2025.

For further insights into KMDA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskKamada’s Strong Growth and Strategic Expansion in 2024
TheFlyKamada reports Q3 EPS 7c, consensus 7c
TheFlyKamada sees FY24 revenue $158M-$162M, consensus $160.47M
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App